glaxosmithkline plc-spon adr
Transactions by GLAXOSMITHKLINE PLC-SPON ADR (GSK) in the last 6 months
GlaxoSmithKline plc (LSE:GSK) acquired 4.96% stake in Valneva SE (ENXTPA:VLA) from Novartis AG (SWX:NOVN) on March 3, 2015.
GlaxoSmithKline plc (LSE:GSK) acquired the remaining stake in GlycoVaxyn AG from Sofinnova Partners, Index Ventures, BioDiscovery 3, FCPR, fund of Edmond de Rothschild Investment Partners, S.A.S., Wellcome Trust, Investment Division and others for $190 million in cash on February 11, 2015. GlycoVaxyn also received funding from the Wellcome Trust and through a collaboration with Janssen Pharmaceuticals. Daniel Piller of IRF Communications acted as public relations advisor ...
Edmond de Rothschild Investment Partners, S.A.S.
Sofinnova Capital V, FCPR
Wellcome Trust, Investment Division
|3M Co||$159.46 USD||+0.38|
|AbbVie Inc||$66.77 USD||+0.15|
|Bayer AG||€130.45 EUR||+2.11|
|Bristol-Myers Squibb Co||$65.71 USD||-0.095|
|Medtronic PLC||$76.54 USD||-0.34|
|View Industry Companies|